StethoMe®

StethoMe®, founded in 2015 and headquartered in Poland, is an innovative AI startup at the intersection of healthcare and technology. The company has developed a revolutionary solution aimed at monitoring children's asthma effectively at home. Their flagship product, which the company describes as "StethoMe®: A smart way of monitoring kid’s asthma," employs advanced medical AI algorithms in conjunction with a wireless, electronic stethoscope and a dedicated application.

This system uniquely allows for the immediate analysis of lung sounds to detect abnormalities, providing instant feedback to parents and facilitating timely telemedicine consultations if necessary. Crucially, both the device and its AI algorithms are professional medical devices certified in the EU as class 2a medical devices (CE 2274), ensuring safety and reliability for home use.

StethoMe® received its last known investment of $1.21M as a grant on 17 November 2020. With its focus on the AI, healthcare, medical devices, and sports industries, StethoMe® represents a significant opportunity for investors looking to impact the future of home healthcare solutions.